Tezel, O., Hutson, T. K., Gist, K. M., Chima, R. S., Goldstein, S. L., & Stanski, N. L. (2023). Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series. Critical care explorations, 5(9), e0978. https://doi.org/10.1097/CCE.0000000000000978
Citácia podle Chicago (17th ed.)Tezel, Oguzhan, Tamara K. Hutson, Katja M. Gist, Ranjit S. Chima, Stuart L. Goldstein, a Natalja L. Stanski. "Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series." Critical Care Explorations 5, no. 9 (2023): e0978. https://doi.org/10.1097/CCE.0000000000000978.
Citácia podľa MLA (8th ed.)Tezel, Oguzhan, et al. "Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series." Critical Care Explorations, vol. 5, no. 9, 2023, p. e0978, https://doi.org/10.1097/CCE.0000000000000978.